The Da Vinci Franchise, on LeaseNarrow moat
Synektik (SNT) — moat facet
Synektik's best asset is a lease on someone else's robot, renewed to 2031 in the same quarter Intuitive bought back three other distributors.
Synektik's most valuable asset is a contract, not a thing it owns. Since 5 July 2018 it has been the exclusive distributor of Intuitive Surgical's da Vinci robots in Poland1. The territory has been widened three times since: Czechia and Slovakia from 1 February 2022, Lithuania, Latvia and Estonia in October 20242, and Ukraine in February 2026, in the same annex that extended the term to 31 December 20313.
The weight of that contract is easy to measure. Intuitive's products were 48,4% of the equipment segment's revenue and 44,9% of the whole group's in the year to September 2025, up from 45,2% and 41,9% a year earlier45. On the buying side the concentration is heavier still: Intuitive supplied 80,2% of the segment's purchases and 72,6% of everything the group bought6. Synektik's own risk section says it sees a dependence on this supplier and its terms, and that losing it could force the group to work with other equipment makers on worse terms than today7.
Why would a manufacturer with an installed base of about 11 710 robots worldwide8 leave a territory to a Warsaw distributor with about 230 staff9? Because the value of a robot is in what happens after the sale: service, training, instruments, and a team in the operating room that keeps the surgeons using it. Synektik looked after 142 authorised da Vinci systems in Poland, Czechia and Slovakia at 30 June 202610, against 37 at the end of September 202211. In Czechia Intuitive went further than tolerating a distributor: in February 2022 Synektik's Czech subsidiary bought two organised parts of Intuitive's own business there12, a manufacturer handing a direct operation to a distributor.
The same manufacturer moved the other way a month after it extended Synektik. On 1 March 2026 Intuitive bought the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for about $533,1 million in cash and became the direct distributor in Italy, Spain and Portugal13. Synektik's filings do not say why one territory was bought back and the other renewed, and a shareholder should not assume the reason is permanent.
The franchise shows up in the pace of hospital contracts. In the fiscal year to September 2025 alone Synektik announced material contracts to supply da Vinci systems to more than a dozen Polish hospitals, from military hospitals in Wrocław, Szczecin, Bydgoszcz and Kraków to university hospitals in Łódź, Białystok and Lublin, and its Czech subsidiary signed contracts with hospitals in Olomouc, Plzeň, Brno, Prague and Bratislava14. Robots under Synektik's care went from 113 at September 202515 to 122 at December16, 132 at March17 and 142 at June 202618, ten a quarter.
So the verdict is a narrow moat that Synektik rents. Within its territory nobody else can sell or service a da Vinci, and the service and instrument revenue that follows each robot is Synektik's until 2031. After that it belongs to whoever Intuitive chooses. The figure to follow is Intuitive's share of group revenue, 44,9%19: rising, it means the franchise is worth more and the dependence is deeper at the same time.
The contract was extended to 2031 and widened twice in eighteen months; the dependence on it rose.
How much of Synektik rests on one supplier's contract; it rose as the robots sold.
Source: Synektik annual management board report, year to September 2025 ↗- ReportedSince 5 July 2018 it has been the exclusive distributor of Intuitive Surgical's da Vinci robots in Poland.Synektik annual management board report for the fiscal year to 30 September 2025 - operating review: da Vinci systems and procedures, orders, recurring revenue, radiopharmaceutical products and the Baltic expansion. — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedThe territory has been widened three times since: Czechia and Slovakia from 1 February 2022, Lithuania, Latvia and Estonia in October 2024, and Ukraine in February 2026, in the same annex that extended the term to 31 December 2031.Synektik annual management board report for the fiscal year to 30 September 2025 - operating review: da Vinci systems and procedures, orders, recurring revenue, radiopharmaceutical products and the Baltic expansion. — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedThe territory has been widened three times since: Czechia and Slovakia from 1 February 2022, Lithuania, Latvia and Estonia in October 2024, and Ukraine in February 2026, in the same annex that extended the term to 31 December 2031.Synektik interim financial statements for 1 October - 31 December 2025 - including the annex extending the da Vinci distribution agreement to 31 December 2031 and adding Ukraine, and the 10,75 złoty dividend. — October - December 2025 · publ. February 2026 · source ↗
- ReportedIntuitive's products were 48,4% of the equipment segment's revenue and 44,9% of the whole group's in the year to September 2025, up from 45,2% and 41,9% a year earlier.Synektik annual management board report for the fiscal year to 30 September 2025 - financial review: margins, net debt, return on equity, working capital and deferred income. — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedIntuitive's products were 48,4% of the equipment segment's revenue and 44,9% of the whole group's in the year to September 2025, up from 45,2% and 41,9% a year earlier.Synektik annual management board report for the fiscal year to 30 September 2024 - Intuitive's share of revenue, public procurement share, installed base and procedures. — October 2023 - September 2024 · publ. December 2024 · source ↗
- ReportedOn the buying side the concentration is heavier still: Intuitive supplied 80,2% of the segment's purchases and 72,6% of everything the group bought.Synektik annual management board report for the fiscal year to 30 September 2025 - risk factors, customers and suppliers (Intuitive's share of revenue and purchases, public procurement, Affidea, seasonality). — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedSynektik's own risk section says it sees a dependence on this supplier and its terms, and that losing it could force the group to work with other equipment makers on worse terms than today.Synektik annual management board report for the fiscal year to 30 September 2025 - risk factors, customers and suppliers (Intuitive's share of revenue and purchases, public procurement, Affidea, seasonality). — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedWhy would a manufacturer with an installed base of about 11 710 robots worldwide leave a territory to a Warsaw distributor with about 230 staff?Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11 710 da Vinci systems up 12%; the 1 March 2026 acquisition of the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for approximately $533,1 million in cash, with $279,8 million of intangible and other assets and $218,0 million of goodwill, making Intuitive the direct distributor in Italy, Spain and Portugal). Same document as Intuitive's own _IS_Q226 record. — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗
- ReportedWhy would a manufacturer with an installed base of about 11 710 robots worldwide leave a territory to a Warsaw distributor with about 230 staff?Synektik factsheet for the third quarter of the 2025 fiscal year - revenue by quarter, the split between contract equipment sales and recurring revenue, Poland against abroad, market value, P/E and free float at 31 July 2026. — Quarter to June 2026 · publ. August 2026 · source ↗
- ReportedSynektik looked after 142 authorised da Vinci systems in Poland, Czechia and Slovakia at 30 June 2026, against 37 at the end of September 2022.Synektik S.A. and Synektik Group interim condensed financial statements for 1 October 2025 - 30 June 2026 (third quarter of the fiscal year) - management commentary: orders, backlog, da Vinci systems and procedures, recurring revenue, radiopharmaceutical sales and seasonality. — October 2025 - June 2026 · publ. 5 August 2026 · source ↗
- ReportedSynektik looked after 142 authorised da Vinci systems in Poland, Czechia and Slovakia at 30 June 2026, against 37 at the end of September 2022.Synektik interim report for the fiscal year to 30 September 2022 - revenue, segments, installed base in Poland, Czechia and Slovakia, the first dedicated reimbursement and example tenders. — October 2021 - September 2022 · publ. November 2022 · source ↗
- ReportedIn Czechia Intuitive went further than tolerating a distributor: in February 2022 Synektik's Czech subsidiary bought two organised parts of Intuitive's own business there, a manufacturer handing a direct operation to a distributor.Synektik annual management board report for the fiscal year to 30 September 2025 - operating review: da Vinci systems and procedures, orders, recurring revenue, radiopharmaceutical products and the Baltic expansion. — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedOn 1 March 2026 Intuitive bought the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for about $533,1 million in cash and became the direct distributor in Italy, Spain and Portugal.Intuitive Surgical Form 10-Q, quarter ended June 30, 2026 (installed base 11 710 da Vinci systems up 12%; the 1 March 2026 acquisition of the da Vinci and Ion distribution businesses of ab medica, Abex and Excelencia Robótica for approximately $533,1 million in cash, with $279,8 million of intangible and other assets and $218,0 million of goodwill, making Intuitive the direct distributor in Italy, Spain and Portugal). Same document as Intuitive's own _IS_Q226 record. — Q2 2026 and the first six months · publ. July 21, 2026 · source ↗
- ReportedIn the fiscal year to September 2025 alone Synektik announced material contracts to supply da Vinci systems to more than a dozen Polish hospitals, from military hospitals in Wrocław, Szczecin, Bydgoszcz and Kraków to university hospitals in Łódź, Białystok and Lublin, and its Czech subsidiary signed contracts with hospitals in Olomouc, Plzeň, Brno, Prague and Bratislava.Synektik annual management board report for the fiscal year to 30 September 2025 - operating review: da Vinci systems and procedures, orders, recurring revenue, radiopharmaceutical products and the Baltic expansion. — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedRobots under Synektik's care went from 113 at September 2025 to 122 at December, 132 at March and 142 at June 2026, ten a quarter.Synektik annual management board report for the fiscal year to 30 September 2025 - financial review: margins, net debt, return on equity, working capital and deferred income. — October 2024 - September 2025 · publ. December 2025 · source ↗
- ReportedRobots under Synektik's care went from 113 at September 2025 to 122 at December, 132 at March and 142 at June 2026, ten a quarter.Synektik interim financial statements for 1 October - 31 December 2025 - including the annex extending the da Vinci distribution agreement to 31 December 2031 and adding Ukraine, and the 10,75 złoty dividend. — October - December 2025 · publ. February 2026 · source ↗
- ReportedRobots under Synektik's care went from 113 at September 2025 to 122 at December, 132 at March and 142 at June 2026, ten a quarter.Synektik management board report for the half-year 1 October 2025 - 31 March 2026 - including the HistoSonics Edison exclusive distribution agreement and the installed base at March 2026. — October 2025 - March 2026 · publ. June 2026 · source ↗
- ReportedRobots under Synektik's care went from 113 at September 2025 to 122 at December, 132 at March and 142 at June 2026, ten a quarter.Synektik S.A. and Synektik Group interim condensed financial statements for 1 October 2025 - 30 June 2026 (third quarter of the fiscal year) - income statement, segment note, cash flow and balance sheet. — October 2025 - June 2026 · publ. 5 August 2026 · source ↗
- ReportedThe figure to follow is Intuitive's share of group revenue, 44,9%: rising, it means the franchise is worth more and the dependence is deeper at the same time.Synektik annual management board report for the fiscal year to 30 September 2025 - risk factors, customers and suppliers (Intuitive's share of revenue and purchases, public procurement, Affidea, seasonality). — October 2024 - September 2025 · publ. December 2025 · source ↗